| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | sodium ion binding | 3.15e-08 | 14 | 49 | 4 | GO:0031402 | |
| GeneOntologyMolecularFunction | transporter activity | ABCA3 ABCB9 SLC25A40 TRPM3 SCN1A PIEZO1 SCN2A SCN3A SCN8A PEX12 ABCB6 ATP11A TRPM1 SLC5A8 CNGA1 ABCG8 | 3.64e-08 | 1289 | 49 | 16 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ABCA3 ABCB9 SLC25A40 TRPM3 SCN1A PIEZO1 SCN2A SCN3A SCN8A PEX12 ABCB6 TRPM1 SLC5A8 CNGA1 ABCG8 | 8.05e-08 | 1180 | 49 | 15 | GO:0022857 |
| GeneOntologyMolecularFunction | sodium channel activity | 1.72e-07 | 52 | 49 | 5 | GO:0005272 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 4.60e-07 | 26 | 49 | 4 | GO:0005248 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 4.60e-07 | 26 | 49 | 4 | GO:0031420 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 1.71e-06 | 343 | 49 | 8 | GO:0005261 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 3.72e-06 | 171 | 49 | 6 | GO:0015081 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 4.59e-06 | 526 | 49 | 9 | GO:0022803 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 6.25e-06 | 49 | 49 | 4 | GO:0140359 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 1.45e-05 | 459 | 49 | 8 | GO:0005216 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 1.59e-05 | 465 | 49 | 8 | GO:0046873 | |
| GeneOntologyMolecularFunction | adiponectin binding | 1.77e-05 | 3 | 49 | 2 | GO:0055100 | |
| GeneOntologyMolecularFunction | acyltransferase activity, transferring groups other than amino-acyl groups | 2.45e-05 | 238 | 49 | 6 | GO:0016747 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 2.94e-05 | 664 | 49 | 9 | GO:0008324 | |
| GeneOntologyMolecularFunction | adipokinetic hormone receptor activity | 3.53e-05 | 4 | 49 | 2 | GO:0097003 | |
| GeneOntologyMolecularFunction | channel activity | 3.78e-05 | 525 | 49 | 8 | GO:0015267 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 1.16e-04 | 793 | 49 | 9 | GO:0015075 | |
| GeneOntologyMolecularFunction | hormone binding | 1.18e-04 | 103 | 49 | 4 | GO:0042562 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 1.31e-04 | 627 | 49 | 8 | GO:0022890 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 1.47e-04 | 109 | 49 | 4 | GO:0042626 | |
| GeneOntologyMolecularFunction | O-acyltransferase activity | 4.10e-04 | 59 | 49 | 3 | GO:0008374 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 4.72e-04 | 758 | 49 | 8 | GO:0015318 | |
| GeneOntologyMolecularFunction | glycerophospholipid flippase activity | 5.27e-04 | 14 | 49 | 2 | GO:0140333 | |
| GeneOntologyMolecularFunction | monoacylglycerol lipase activity | 6.93e-04 | 16 | 49 | 2 | GO:0047372 | |
| GeneOntologyMolecularFunction | oligopeptide transmembrane transporter activity | 6.93e-04 | 16 | 49 | 2 | GO:0035673 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 7.84e-04 | 17 | 49 | 2 | GO:0099508 | |
| GeneOntologyMolecularFunction | flippase activity | 7.84e-04 | 17 | 49 | 2 | GO:0140327 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 9.28e-04 | 78 | 49 | 3 | GO:0008080 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 9.46e-04 | 178 | 49 | 4 | GO:0015399 | |
| GeneOntologyMolecularFunction | protein-hormone receptor activity | 1.32e-03 | 22 | 49 | 2 | GO:0016500 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 1.35e-03 | 196 | 49 | 4 | GO:0005319 | |
| GeneOntologyMolecularFunction | triacylglycerol lipase activity | 1.85e-03 | 26 | 49 | 2 | GO:0004806 | |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 2.01e-03 | 102 | 49 | 3 | GO:0016410 | |
| GeneOntologyMolecularFunction | acetyltransferase activity | 2.12e-03 | 104 | 49 | 3 | GO:0016407 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 2.14e-03 | 28 | 49 | 2 | GO:0140326 | |
| GeneOntologyMolecularFunction | acyltransferase activity | 2.68e-03 | 775 | 49 | 7 | GO:0016746 | |
| GeneOntologyMolecularFunction | palmitoyltransferase activity | 3.72e-03 | 37 | 49 | 2 | GO:0016409 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 3.75e-03 | 614 | 49 | 6 | GO:0140657 | |
| GeneOntologyMolecularFunction | calcium channel activity | 3.91e-03 | 129 | 49 | 3 | GO:0005262 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 4.41e-03 | 441 | 49 | 5 | GO:0016887 | |
| GeneOntologyMolecularFunction | lipase activity | 4.72e-03 | 138 | 49 | 3 | GO:0016298 | |
| GeneOntologyMolecularFunction | amide transmembrane transporter activity | 4.77e-03 | 42 | 49 | 2 | GO:0042887 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 6.06e-03 | 151 | 49 | 3 | GO:0015085 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 6.12e-03 | 477 | 49 | 5 | GO:0022804 | |
| GeneOntologyMolecularFunction | carboxylic ester hydrolase activity | 6.74e-03 | 157 | 49 | 3 | GO:0052689 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 6.97e-03 | 51 | 49 | 2 | GO:0140303 | |
| GeneOntologyMolecularFunction | lipid transfer activity | 8.64e-03 | 57 | 49 | 2 | GO:0120013 | |
| GeneOntologyMolecularFunction | gated channel activity | 9.02e-03 | 334 | 49 | 4 | GO:0022836 | |
| GeneOntologyMolecularFunction | phospholipid transporter activity | 1.42e-02 | 74 | 49 | 2 | GO:0005548 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 1.70e-06 | 36 | 50 | 4 | GO:0086010 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 1.10e-05 | 121 | 50 | 5 | GO:0051899 | |
| GeneOntologyBiologicalProcess | fatty acid metabolic process | 1.38e-05 | 461 | 50 | 8 | GO:0006631 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 1.54e-05 | 62 | 50 | 4 | GO:0086002 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 1.64e-05 | 63 | 50 | 4 | GO:0019228 | |
| GeneOntologyBiologicalProcess | cannabinoid biosynthetic process | 1.73e-05 | 3 | 50 | 2 | GO:1901696 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 5.17e-05 | 275 | 50 | 6 | GO:0006814 | |
| GeneOntologyBiologicalProcess | diacylglycerol catabolic process | 5.73e-05 | 5 | 50 | 2 | GO:0046340 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 5.86e-05 | 87 | 50 | 4 | GO:0086001 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | TRPM3 SCN1A PIEZO1 SCN2A SCN3A AGTR1 SCN8A ABCB6 TRPM1 CNGA1 | 7.31e-05 | 942 | 50 | 10 | GO:0098655 |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 7.61e-05 | 93 | 50 | 4 | GO:0086003 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | TRPM3 SCN1A PIEZO1 SCN2A SCN3A AGTR1 SCN8A ABCB6 TRPM1 SLC5A8 CNGA1 | 8.15e-05 | 1157 | 50 | 11 | GO:0006812 |
| GeneOntologyBiologicalProcess | metal ion transport | TRPM3 SCN1A SCN2A SCN3A AGTR1 SCN8A ABCB6 TRPM1 SLC5A8 CNGA1 | 1.20e-04 | 1000 | 50 | 10 | GO:0030001 |
| GeneOntologyBiologicalProcess | adiponectin-activated signaling pathway | 1.20e-04 | 7 | 50 | 2 | GO:0033211 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | TRPM3 SCN1A SCN2A SCN3A AGTR1 SCN8A ABCB6 TRPM1 SLC5A8 CNGA1 | 1.38e-04 | 1017 | 50 | 10 | GO:0098660 |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 1.46e-04 | 208 | 50 | 5 | GO:0035725 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 1.56e-04 | 112 | 50 | 4 | GO:0019226 | |
| GeneOntologyBiologicalProcess | lipid modification | 1.66e-04 | 214 | 50 | 5 | GO:0030258 | |
| GeneOntologyBiologicalProcess | monoacylglycerol biosynthetic process | 2.05e-04 | 9 | 50 | 2 | GO:0006640 | |
| GeneOntologyBiologicalProcess | putrescine metabolic process | 2.05e-04 | 9 | 50 | 2 | GO:0009445 | |
| GeneOntologyBiologicalProcess | lipid transport | 2.06e-04 | 506 | 50 | 7 | GO:0006869 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound transport | 2.19e-04 | 358 | 50 | 6 | GO:0015850 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid metabolic process | 2.31e-04 | 124 | 50 | 4 | GO:0001676 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 2.54e-04 | 127 | 50 | 4 | GO:0070252 | |
| GeneOntologyBiologicalProcess | lipid oxidation | 2.69e-04 | 129 | 50 | 4 | GO:0034440 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | TRPM3 SCN1A PIEZO1 SCN2A SCN3A AGTR1 SCN8A ABCB6 TRPM1 CNGA1 | 2.91e-04 | 1115 | 50 | 10 | GO:0034220 |
| GeneOntologyBiologicalProcess | regulation of myotube differentiation | 3.22e-04 | 55 | 50 | 3 | GO:0010830 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | 3.29e-04 | 922 | 50 | 9 | GO:0098662 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid metabolic process | 3.44e-04 | 731 | 50 | 8 | GO:0032787 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | TRPM3 SCN1A PIEZO1 SCN2A SCN3A AGTR1 SCN8A ABCB6 TRPM1 SLC5A8 CNGA1 | 3.68e-04 | 1374 | 50 | 11 | GO:0006811 |
| GeneOntologyBiologicalProcess | lipid localization | 4.01e-04 | 565 | 50 | 7 | GO:0010876 | |
| GeneOntologyBiologicalProcess | neutral lipid biosynthetic process | 4.80e-04 | 63 | 50 | 3 | GO:0046460 | |
| GeneOntologyBiologicalProcess | acylglycerol biosynthetic process | 4.80e-04 | 63 | 50 | 3 | GO:0046463 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 5.14e-04 | 153 | 50 | 4 | GO:0030048 | |
| GeneOntologyBiologicalProcess | arachidonate metabolic process | 6.01e-04 | 68 | 50 | 3 | GO:0019369 | |
| GeneOntologyBiologicalProcess | monoacylglycerol metabolic process | 6.76e-04 | 16 | 50 | 2 | GO:0046462 | |
| GeneOntologyBiologicalProcess | G protein-coupled glutamate receptor signaling pathway | 6.76e-04 | 16 | 50 | 2 | GO:0007216 | |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 7.14e-04 | 167 | 50 | 4 | GO:0060048 | |
| GeneOntologyBiologicalProcess | carboxylic acid metabolic process | 7.61e-04 | 1035 | 50 | 9 | GO:0019752 | |
| GeneOntologyBiologicalProcess | oligopeptide transmembrane transport | 7.65e-04 | 17 | 50 | 2 | GO:0035672 | |
| GeneOntologyBiologicalProcess | cholesterol efflux | 8.64e-04 | 77 | 50 | 3 | GO:0033344 | |
| GeneOntologyBiologicalProcess | oxoacid metabolic process | 8.90e-04 | 1058 | 50 | 9 | GO:0043436 | |
| GeneOntologyBiologicalProcess | phosphatidylcholine metabolic process | 8.97e-04 | 78 | 50 | 3 | GO:0046470 | |
| GeneOntologyBiologicalProcess | blood circulation | 9.03e-04 | 648 | 50 | 7 | GO:0008015 | |
| GeneOntologyBiologicalProcess | organic acid metabolic process | 9.26e-04 | 1064 | 50 | 9 | GO:0006082 | |
| GeneOntologyBiologicalProcess | positive regulation of myotube differentiation | 9.59e-04 | 19 | 50 | 2 | GO:0010831 | |
| GeneOntologyBiologicalProcess | polyamine metabolic process | 1.06e-03 | 20 | 50 | 2 | GO:0006595 | |
| GeneOntologyBiologicalProcess | fatty acid biosynthetic process | 1.18e-03 | 191 | 50 | 4 | GO:0006633 | |
| GeneOntologyBiologicalProcess | fatty acid transmembrane transport | 1.29e-03 | 22 | 50 | 2 | GO:1902001 | |
| GeneOntologyBiologicalProcess | oligopeptide transport | 1.41e-03 | 23 | 50 | 2 | GO:0006857 | |
| GeneOntologyBiologicalProcess | action potential | 1.42e-03 | 201 | 50 | 4 | GO:0001508 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | 1.65e-03 | 1395 | 50 | 10 | GO:0007186 | |
| GeneOntologyBiologicalProcess | NAD biosynthetic process | 1.80e-03 | 26 | 50 | 2 | GO:0009435 | |
| GeneOntologyBiologicalProcess | circulatory system process | 1.84e-03 | 733 | 50 | 7 | GO:0003013 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | 1.88e-03 | 217 | 50 | 4 | GO:0006941 | |
| GeneOntologyBiologicalProcess | positive regulation of cold-induced thermogenesis | 1.94e-03 | 102 | 50 | 3 | GO:0120162 | |
| GeneOntologyBiologicalProcess | positive regulation of cholesterol efflux | 1.94e-03 | 27 | 50 | 2 | GO:0010875 | |
| GeneOntologyBiologicalProcess | diacylglycerol metabolic process | 2.09e-03 | 28 | 50 | 2 | GO:0046339 | |
| GeneOntologyBiologicalProcess | phospholipid transport | 2.17e-03 | 106 | 50 | 3 | GO:0015914 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | 2.23e-03 | 559 | 50 | 6 | GO:0042391 | |
| GeneOntologyBiologicalProcess | N-terminal protein amino acid modification | 2.24e-03 | 29 | 50 | 2 | GO:0031365 | |
| GeneOntologyBiologicalProcess | lipid catabolic process | 2.27e-03 | 382 | 50 | 5 | GO:0016042 | |
| GeneOntologyBiologicalProcess | visual perception | 2.32e-03 | 230 | 50 | 4 | GO:0007601 | |
| GeneOntologyBiologicalProcess | nerve development | 2.35e-03 | 109 | 50 | 3 | GO:0021675 | |
| GeneOntologyBiologicalProcess | nicotinamide nucleotide biosynthetic process | 2.40e-03 | 30 | 50 | 2 | GO:0019359 | |
| GeneOntologyBiologicalProcess | pyridine nucleotide biosynthetic process | 2.40e-03 | 30 | 50 | 2 | GO:0019363 | |
| GeneOntologyBiologicalProcess | sensory perception of light stimulus | 2.43e-03 | 233 | 50 | 4 | GO:0050953 | |
| GeneOntologyBiologicalProcess | muscle contraction | 2.77e-03 | 400 | 50 | 5 | GO:0006936 | |
| GeneOntologyBiologicalProcess | cellular catabolic process | 2.87e-03 | 1253 | 50 | 9 | GO:0044248 | |
| GeneOntologyBiologicalProcess | pyridine-containing compound biosynthetic process | 3.07e-03 | 34 | 50 | 2 | GO:0072525 | |
| GeneOntologyBiologicalProcess | phospholipid metabolic process | 3.08e-03 | 410 | 50 | 5 | GO:0006644 | |
| GeneOntologyBiologicalProcess | biogenic amine metabolic process | 3.16e-03 | 121 | 50 | 3 | GO:0006576 | |
| GeneOntologyBiologicalProcess | fatty acid oxidation | 3.23e-03 | 122 | 50 | 3 | GO:0019395 | |
| GeneOntologyBiologicalProcess | phosphatidylglycerol metabolic process | 3.26e-03 | 35 | 50 | 2 | GO:0046471 | |
| GeneOntologyBiologicalProcess | lipid biosynthetic process | 3.28e-03 | 813 | 50 | 7 | GO:0008610 | |
| GeneOntologyBiologicalProcess | regulation of striated muscle cell differentiation | 3.31e-03 | 123 | 50 | 3 | GO:0051153 | |
| GeneOntologyBiologicalProcess | plasma lipoprotein particle remodeling | 3.44e-03 | 36 | 50 | 2 | GO:0034369 | |
| GeneOntologyBiologicalProcess | protein-lipid complex remodeling | 3.44e-03 | 36 | 50 | 2 | GO:0034368 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 7.30e-08 | 17 | 51 | 4 | GO:0001518 | |
| GeneOntologyCellularComponent | transporter complex | NDUFAF1 SCN1A SCN2A SCN3A SCN8A PEX12 ABCB6 ATP11A CNGA1 ABCG8 | 7.10e-07 | 550 | 51 | 10 | GO:1990351 |
| GeneOntologyCellularComponent | sodium channel complex | 7.13e-07 | 29 | 51 | 4 | GO:0034706 | |
| GeneOntologyCellularComponent | node of Ranvier | 1.51e-05 | 20 | 51 | 3 | GO:0033268 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 3.60e-05 | 523 | 51 | 8 | GO:1902495 | |
| GeneOntologyCellularComponent | axon initial segment | 4.78e-05 | 29 | 51 | 3 | GO:0043194 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | ABCB9 PIEZO1 TECR HHAT PON1 LPGAT1 ABCB6 ATP11A TRPM1 PLPP6 STT3B RHO | 4.97e-05 | 1293 | 51 | 12 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | ABCB9 PIEZO1 TECR HHAT PON1 LPGAT1 ABCB6 ATP11A TRPM1 PLPP6 STT3B RHO | 5.20e-05 | 1299 | 51 | 12 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | ABCB9 PIEZO1 TECR HHAT PON1 LPGAT1 ABCB6 ATP11A TRPM1 PLPP6 STT3B RHO | 6.39e-05 | 1327 | 51 | 12 | GO:0042175 |
| GeneOntologyCellularComponent | main axon | 6.58e-05 | 89 | 51 | 4 | GO:0044304 | |
| GeneOntologyCellularComponent | ATP-binding cassette (ABC) transporter complex | 8.70e-05 | 6 | 51 | 2 | GO:0043190 | |
| GeneOntologyCellularComponent | rod photoreceptor outer segment | 2.08e-04 | 9 | 51 | 2 | GO:0120200 | |
| GeneOntologyCellularComponent | cation channel complex | 2.65e-04 | 235 | 51 | 5 | GO:0034703 | |
| GeneOntologyCellularComponent | lysosomal membrane | 8.75e-04 | 462 | 51 | 6 | GO:0005765 | |
| GeneOntologyCellularComponent | lytic vacuole membrane | 8.75e-04 | 462 | 51 | 6 | GO:0098852 | |
| GeneOntologyCellularComponent | photoreceptor outer segment membrane | 9.72e-04 | 19 | 51 | 2 | GO:0042622 | |
| GeneOntologyCellularComponent | axon | 1.32e-03 | 891 | 51 | 8 | GO:0030424 | |
| GeneOntologyCellularComponent | vacuolar membrane | 1.41e-03 | 507 | 51 | 6 | GO:0005774 | |
| GeneOntologyCellularComponent | endosome | 1.86e-03 | 1167 | 51 | 9 | GO:0005768 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 2.24e-03 | 378 | 51 | 5 | GO:0034702 | |
| GeneOntologyCellularComponent | multivesicular body membrane | 2.43e-03 | 30 | 51 | 2 | GO:0032585 | |
| GeneOntologyCellularComponent | lysosome | 3.37e-03 | 811 | 51 | 7 | GO:0005764 | |
| GeneOntologyCellularComponent | lytic vacuole | 3.37e-03 | 811 | 51 | 7 | GO:0000323 | |
| GeneOntologyCellularComponent | cell projection membrane | 3.92e-03 | 431 | 51 | 5 | GO:0031253 | |
| GeneOntologyCellularComponent | early endosome | 6.22e-03 | 481 | 51 | 5 | GO:0005769 | |
| GeneOntologyCellularComponent | vacuole | 6.42e-03 | 913 | 51 | 7 | GO:0005773 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 6.65e-03 | 157 | 51 | 3 | GO:0098839 | |
| GeneOntologyCellularComponent | specific granule | 7.00e-03 | 160 | 51 | 3 | GO:0042581 | |
| GeneOntologyCellularComponent | ATPase dependent transmembrane transport complex | 7.98e-03 | 55 | 51 | 2 | GO:0098533 | |
| HumanPheno | Simple febrile seizure | 1.01e-05 | 27 | 27 | 4 | HP:0011171 | |
| HumanPheno | Focal automatism seizure | 2.83e-05 | 12 | 27 | 3 | HP:0032898 | |
| HumanPheno | Complex febrile seizure | 7.10e-05 | 16 | 27 | 3 | HP:0011172 | |
| HumanPheno | Episodic hemolytic anemia | 8.09e-05 | 3 | 27 | 2 | HP:0004802 | |
| HumanPheno | Macrovesicular hepatic steatosis | 8.60e-05 | 17 | 27 | 3 | HP:0001403 | |
| HumanPheno | Dermatological manifestations of systemic disorders | 2.58e-04 | 435 | 27 | 9 | HP:0001005 | |
| HumanPheno | Neonatal electro-clinical non-motor seizure | 2.68e-04 | 5 | 27 | 2 | HP:0032812 | |
| HumanPheno | Neonatal seizure with electrographic correlate | 2.68e-04 | 5 | 27 | 2 | HP:0032808 | |
| HumanPheno | Neonatal electro-clinical seizure | 2.68e-04 | 5 | 27 | 2 | HP:0032809 | |
| HumanPheno | Neonatal electro-clinical seizure with behavior arrest | 2.68e-04 | 5 | 27 | 2 | HP:0032823 | |
| HumanPheno | Focal head nodding automatism seizure | 2.68e-04 | 5 | 27 | 2 | HP:0032906 | |
| HumanPheno | Focal hemiclonic seizure | 2.83e-04 | 25 | 27 | 3 | HP:0006813 | |
| HumanPheno | Intellectual disability, borderline | 2.83e-04 | 25 | 27 | 3 | HP:0006889 | |
| HumanPheno | Cyanosis | 3.16e-04 | 117 | 27 | 5 | HP:0000961 | |
| MousePheno | absent b-wave | 3.17e-05 | 3 | 46 | 2 | MP:0020439 | |
| Domain | Na_trans_cytopl | 7.37e-10 | 6 | 51 | 4 | PF11933 | |
| Domain | Na_trans_cytopl | 7.37e-10 | 6 | 51 | 4 | IPR024583 | |
| Domain | Na_channel_asu | 1.02e-08 | 10 | 51 | 4 | IPR001696 | |
| Domain | Na_trans_assoc | 1.02e-08 | 10 | 51 | 4 | IPR010526 | |
| Domain | Na_trans_assoc | 1.02e-08 | 10 | 51 | 4 | PF06512 | |
| Domain | Ion_trans_dom | 2.43e-08 | 114 | 51 | 7 | IPR005821 | |
| Domain | Ion_trans | 2.43e-08 | 114 | 51 | 7 | PF00520 | |
| Domain | ABC_transporter_CS | 5.11e-06 | 42 | 51 | 4 | IPR017871 | |
| Domain | Fungal_lipase-like | 7.31e-06 | 2 | 51 | 2 | IPR002921 | |
| Domain | Lipase_3 | 7.31e-06 | 2 | 51 | 2 | PF01764 | |
| Domain | ABC_TRANSPORTER_2 | 8.78e-06 | 48 | 51 | 4 | PS50893 | |
| Domain | ABC_tran | 8.78e-06 | 48 | 51 | 4 | PF00005 | |
| Domain | ABC_TRANSPORTER_1 | 9.54e-06 | 49 | 51 | 4 | PS00211 | |
| Domain | ABC_transporter-like | 1.04e-05 | 50 | 51 | 4 | IPR003439 | |
| Domain | Channel_four-helix_dom | 1.75e-05 | 57 | 51 | 4 | IPR027359 | |
| Domain | - | 1.75e-05 | 57 | 51 | 4 | 1.20.120.350 | |
| Domain | TRPM_tetra | 4.37e-05 | 4 | 51 | 2 | PF16519 | |
| Domain | TRPM_tetra | 4.37e-05 | 4 | 51 | 2 | IPR032415 | |
| Domain | IQ | 7.03e-05 | 81 | 51 | 4 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 1.06e-04 | 90 | 51 | 4 | IPR000048 | |
| Domain | IQ | 1.20e-04 | 93 | 51 | 4 | PS50096 | |
| Domain | 7TM_GPCR_Srsx | 2.46e-04 | 112 | 51 | 4 | SM01381 | |
| Domain | AdipoR/HlyIII-related | 3.96e-04 | 11 | 51 | 2 | IPR004254 | |
| Domain | HlyIII | 3.96e-04 | 11 | 51 | 2 | PF03006 | |
| Domain | IQ | 9.62e-04 | 71 | 51 | 3 | PF00612 | |
| Domain | Acetyltransf_1 | 1.78e-03 | 23 | 51 | 2 | PF00583 | |
| Domain | ABC_membrane | 1.94e-03 | 24 | 51 | 2 | PF00664 | |
| Domain | GNAT | 2.11e-03 | 25 | 51 | 2 | PS51186 | |
| Domain | GNAT_dom | 2.11e-03 | 25 | 51 | 2 | IPR000182 | |
| Domain | LIPASE_SER | 2.28e-03 | 26 | 51 | 2 | PS00120 | |
| Domain | ABC_TM1F | 2.64e-03 | 28 | 51 | 2 | PS50929 | |
| Domain | ABC1_TM_dom | 2.64e-03 | 28 | 51 | 2 | IPR011527 | |
| Domain | - | 5.08e-03 | 39 | 51 | 2 | 2.120.10.30 | |
| Domain | - | 5.34e-03 | 40 | 51 | 2 | 3.40.630.30 | |
| Domain | Acyl_CoA_acyltransferase | 6.71e-03 | 45 | 51 | 2 | IPR016181 | |
| Domain | 6-blade_b-propeller_TolB-like | 7.01e-03 | 46 | 51 | 2 | IPR011042 | |
| Domain | AAA+_ATPase | 7.13e-03 | 144 | 51 | 3 | IPR003593 | |
| Domain | AAA | 7.13e-03 | 144 | 51 | 3 | SM00382 | |
| Pathway | WP_DRAVET_SYNDROME | 1.92e-06 | 28 | 46 | 4 | M45519 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | 2.34e-06 | 367 | 46 | 9 | M48346 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 2.93e-06 | 31 | 46 | 4 | M877 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 3.34e-06 | 32 | 46 | 4 | M27455 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 1.22e-05 | 44 | 46 | 4 | M11911 | |
| Pathway | WP_RETT_SYNDROME | 1.74e-05 | 48 | 46 | 4 | M39759 | |
| Pathway | REACTOME_ARACHIDONATE_PRODUCTION_FROM_DAG | 1.04e-04 | 5 | 46 | 2 | M27338 | |
| Pathway | REACTOME_ARACHIDONATE_PRODUCTION_FROM_DAG | 1.04e-04 | 5 | 46 | 2 | MM15080 | |
| Pathway | REACTOME_AMPK_INHIBITS_CHREBP_TRANSCRIPTIONAL_ACTIVATION_ACTIVITY | 1.55e-04 | 6 | 46 | 2 | MM14630 | |
| Pathway | REACTOME_AMPK_INHIBITS_CHREBP_TRANSCRIPTIONAL_ACTIVATION_ACTIVITY | 2.88e-04 | 8 | 46 | 2 | M26990 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_PHOTOTRANSDUCTION_CASCADE | 2.88e-04 | 8 | 46 | 2 | MM14893 | |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 2.98e-04 | 99 | 46 | 4 | MM14986 | |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 3.47e-04 | 103 | 46 | 4 | M758 | |
| Pathway | WP_LEPTIN_AND_ADIPONECTIN | 4.61e-04 | 10 | 46 | 2 | M39539 | |
| Pathway | WP_LEPTIN_AND_ADIPONECTIN | 4.61e-04 | 10 | 46 | 2 | MM15824 | |
| Pathway | REACTOME_SENSORY_PERCEPTION_OF_TASTE | 4.77e-04 | 47 | 46 | 3 | M42524 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_PHOTOTRANSDUCTION_CASCADE | 5.62e-04 | 11 | 46 | 2 | M27180 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 6.38e-04 | 121 | 46 | 4 | M872 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 8.35e-04 | 130 | 46 | 4 | M27454 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | 1.04e-03 | 646 | 46 | 8 | MM14962 | |
| Pathway | KEGG_RENIN_ANGIOTENSIN_SYSTEM | 1.37e-03 | 17 | 46 | 2 | M17636 | |
| Pathway | REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | 1.37e-03 | 17 | 46 | 2 | MM14552 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 1.46e-03 | 681 | 46 | 8 | MM14985 | |
| Pathway | REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | 1.54e-03 | 18 | 46 | 2 | M524 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 1.66e-03 | 72 | 46 | 3 | MM14631 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | 1.76e-03 | 702 | 46 | 8 | M746 | |
| Pathway | REACTOME_ABC_TRANSPORTER_DISORDERS | 2.08e-03 | 78 | 46 | 3 | M27473 | |
| Pathway | REACTOME_FATTY_ACID_METABOLISM | 2.25e-03 | 170 | 46 | 4 | MM15573 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 2.38e-03 | 736 | 46 | 8 | M27287 | |
| Pathway | PID_RHODOPSIN_PATHWAY | 2.52e-03 | 23 | 46 | 2 | M204 | |
| Pathway | REACTOME_SURFACTANT_METABOLISM | 2.52e-03 | 23 | 46 | 2 | MM15279 | |
| Pathway | REACTOME_FATTY_ACID_METABOLISM | 2.55e-03 | 176 | 46 | 4 | M27854 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | 2.59e-03 | 430 | 46 | 6 | MM15160 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 2.98e-03 | 25 | 46 | 2 | MM14511 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 3.11e-03 | 186 | 46 | 4 | MM15994 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 3.47e-03 | 27 | 46 | 2 | M12123 | |
| Pathway | REACTOME_METABOLISM_OF_LIPIDS | 3.70e-03 | 620 | 46 | 7 | MM15193 | |
| Pathway | REACTOME_TRP_CHANNELS | 3.73e-03 | 28 | 46 | 2 | MM14943 | |
| Pathway | REACTOME_TRP_CHANNELS | 3.73e-03 | 28 | 46 | 2 | M27241 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | 3.74e-03 | 463 | 46 | 6 | M507 | |
| Pathway | WP_CANNABINOID_RECEPTOR_SIGNALING | 4.00e-03 | 29 | 46 | 2 | M39676 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 4.25e-03 | 203 | 46 | 4 | M5485 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 4.26e-03 | 330 | 46 | 5 | M18334 | |
| Pathway | REACTOME_SURFACTANT_METABOLISM | 4.28e-03 | 30 | 46 | 2 | M27566 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 4.42e-03 | 333 | 46 | 5 | MM14963 | |
| Pathway | REACTOME_NICOTINATE_METABOLISM | 4.56e-03 | 31 | 46 | 2 | M27089 | |
| Pathway | REACTOME_NICOTINATE_METABOLISM | 4.56e-03 | 31 | 46 | 2 | MM14767 | |
| Pathway | REACTOME_THE_PHOTOTRANSDUCTION_CASCADE | 4.56e-03 | 31 | 46 | 2 | MM14896 | |
| Pathway | WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2 | 5.16e-03 | 33 | 46 | 2 | M40066 | |
| Pathway | PID_NCADHERIN_PATHWAY | 5.16e-03 | 33 | 46 | 2 | M266 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 5.23e-03 | 108 | 46 | 3 | M17034 | |
| Pathway | REACTOME_THE_PHOTOTRANSDUCTION_CASCADE | 5.47e-03 | 34 | 46 | 2 | M27183 | |
| Pubmed | 4.80e-12 | 4 | 53 | 4 | 17537961 | ||
| Pubmed | 4.80e-12 | 4 | 53 | 4 | 35031483 | ||
| Pubmed | 4.80e-12 | 4 | 53 | 4 | 29578003 | ||
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 7.19e-11 | 6 | 53 | 4 | 23652591 | |
| Pubmed | 6.02e-10 | 9 | 53 | 4 | 16382098 | ||
| Pubmed | 6.02e-10 | 9 | 53 | 4 | 15746173 | ||
| Pubmed | Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice. | 2.36e-09 | 12 | 53 | 4 | 30175250 | |
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 12610651 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 23859570 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 18784617 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 17544618 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 32845893 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 28518218 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 17928448 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 14973256 | ||
| Pubmed | 3.40e-09 | 13 | 53 | 4 | 15123669 | ||
| Pubmed | 1.34e-08 | 4 | 53 | 3 | 21156207 | ||
| Pubmed | 1.34e-08 | 4 | 53 | 3 | 35801810 | ||
| Pubmed | Use of recombinant inbred strains for studying genetic determinants of responses to alcohol. | 1.34e-08 | 4 | 53 | 3 | 8974318 | |
| Pubmed | 3.33e-08 | 5 | 53 | 3 | 1679748 | ||
| Pubmed | 3.33e-08 | 5 | 53 | 3 | 8812438 | ||
| Pubmed | 3.33e-08 | 5 | 53 | 3 | 17724025 | ||
| Pubmed | 3.33e-08 | 5 | 53 | 3 | 24337656 | ||
| Pubmed | Diagnostic yield of genetic testing in epileptic encephalopathy in childhood. | 1.16e-07 | 7 | 53 | 3 | 25818041 | |
| Pubmed | 7.28e-07 | 12 | 53 | 3 | 8169823 | ||
| Pubmed | Confirmation of quantitative trait loci for alcohol preference in mice. | 1.50e-06 | 15 | 53 | 3 | 9726281 | |
| Pubmed | Adiponectin receptor-1 expression is decreased in the pancreas of obese mice. | 2.28e-06 | 2 | 53 | 2 | 19062045 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 29649454 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 20028965 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 21278253 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 24969908 | ||
| Pubmed | Adiponectin and adiponectin receptor in relation to colorectal cancer progression. | 2.28e-06 | 2 | 53 | 2 | 21351255 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 20346423 | ||
| Pubmed | Reduction of Kcnt1 is therapeutic in mouse models of SCN1A and SCN8A epilepsy. | 2.28e-06 | 2 | 53 | 2 | 37901435 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 22534793 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 15331527 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 19909601 | ||
| Pubmed | An Scn1a epilepsy mutation in Scn8a alters seizure susceptibility and behavior. | 2.28e-06 | 2 | 53 | 2 | 26410685 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 29237572 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 17416799 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 28145500 | ||
| Pubmed | AdipoR agonist increases insulin sensitivity and exercise endurance in AdipoR-humanized mice. | 2.28e-06 | 2 | 53 | 2 | 33420419 | |
| Pubmed | Neuronal death and perinatal lethality in voltage-gated sodium channel alpha(II)-deficient mice. | 2.28e-06 | 2 | 53 | 2 | 10827969 | |
| Pubmed | Adiponectin receptor expression predicts favorable prognosis in cases of hepatocellular carcinoma. | 2.28e-06 | 2 | 53 | 2 | 24619866 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 19694741 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 35348308 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 18988888 | ||
| Pubmed | Genomic structures of SCN2A and SCN3A - candidate genes for deafness at the DFNA16 locus. | 2.28e-06 | 2 | 53 | 2 | 11245985 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 14610053 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 19549705 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 20147530 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 15760941 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 25392268 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 18923878 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 15918014 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 18842004 | ||
| Pubmed | Differential expression of two sodium channel subtypes in human brain. | 2.28e-06 | 2 | 53 | 2 | 1317301 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 21807615 | ||
| Pubmed | Duplication of the sodium channel gene cluster on 2q24 in children with early onset epilepsy. | 2.28e-06 | 2 | 53 | 2 | 23016767 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 17216283 | ||
| Pubmed | Dual action of adiponectin on insulin secretion in insulin-resistant mice. | 2.28e-06 | 2 | 53 | 2 | 15358228 | |
| Pubmed | Regulation of adiponectin receptor gene expression in diabetic mice. | 2.28e-06 | 2 | 53 | 2 | 15613685 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 27153334 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 33096315 | ||
| Pubmed | Electrophysiological Differences between the Same Pore Region Mutation in SCN1A and SCN3A. | 2.28e-06 | 2 | 53 | 2 | 24990319 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 16724230 | ||
| Pubmed | DAGL-Beta Functions as a PUFA-Specific Triacylglycerol Lipase in Macrophages. | 2.28e-06 | 2 | 53 | 2 | 31991095 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 31439038 | ||
| Pubmed | Demonstration of adiponectin receptors 1 and 2 mRNA expression in human breast cancer cells. | 2.28e-06 | 2 | 53 | 2 | 17123704 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 30890562 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 26668358 | ||
| Pubmed | The regulation of adiponectin receptors in human prostate cancer cell lines. | 2.28e-06 | 2 | 53 | 2 | 16899222 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 26111083 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 17001470 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 36429712 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 19878661 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 29145541 | ||
| Pubmed | Sodium channel expression within chronic multiple sclerosis plaques. | 2.28e-06 | 2 | 53 | 2 | 17805013 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 27288489 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 23358721 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 26311622 | ||
| Pubmed | Expression profiles of adiponectin receptors in mouse embryos. | 2.28e-06 | 2 | 53 | 2 | 15939384 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 33411788 | ||
| Pubmed | Expression and biologic significance of adiponectin receptors in papillary thyroid carcinoma. | 2.28e-06 | 2 | 53 | 2 | 22907586 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 25892445 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 23255609 | ||
| Pubmed | Polymorphisms in adiponectin receptor genes ADIPOR1 and ADIPOR2 and insulin resistance. | 2.28e-06 | 2 | 53 | 2 | 17716299 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 20470935 | ||
| Pubmed | Adipo-R1 and adipo-R2 expression in colorectal adenomas and carcinomas. | 2.28e-06 | 2 | 53 | 2 | 25640382 | |
| Pubmed | The expression and relationship of AdipoR1/R2 in gastric intestinal metaplasia. | 2.28e-06 | 2 | 53 | 2 | 33851685 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 17459059 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 31943325 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 18310295 | ||
| Pubmed | The effect of renal transplantation on adiponectin and its isoforms and receptors. | 2.28e-06 | 2 | 53 | 2 | 17697862 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 21186369 | ||
| Pubmed | Severe epilepsy, retardation, and dysmorphic features with a 2q deletion including SCN1A and SCN2A. | 2.28e-06 | 2 | 53 | 2 | 15249644 | |
| Pubmed | Expressions of adiponectin receptors in placenta and their correlation with preeclampsia. | 2.28e-06 | 2 | 53 | 2 | 19487733 | |
| Pubmed | Polymorphisms of ADIPOR1 and ADIPOR2 are associated with phenotypes of type 2 diabetes in Koreans. | 2.28e-06 | 2 | 53 | 2 | 18466348 | |
| Pubmed | Association of ADIPOR2 with liver function tests in type 2 diabetic subjects. | 2.28e-06 | 2 | 53 | 2 | 18719649 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 18971219 | ||
| Interaction | SCN4B interactions | 8.47e-07 | 8 | 51 | 3 | int:SCN4B | |
| Interaction | TTYH1 interactions | 9.98e-06 | 300 | 51 | 7 | int:TTYH1 | |
| Interaction | GPBAR1 interactions | 6.53e-05 | 31 | 51 | 3 | int:GPBAR1 | |
| Interaction | MBOAT1 interactions | 7.90e-05 | 33 | 51 | 3 | int:MBOAT1 | |
| Interaction | LRRC25 interactions | 1.03e-04 | 185 | 51 | 5 | int:LRRC25 | |
| Interaction | C3orf52 interactions | 1.16e-04 | 305 | 51 | 6 | int:C3orf52 | |
| Cytoband | 2q24.3 | 1.55e-04 | 16 | 53 | 2 | 2q24.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q24 | 4.38e-04 | 127 | 53 | 3 | chr2q24 | |
| Cytoband | 11q12.2 | 9.43e-04 | 39 | 53 | 2 | 11q12.2 | |
| Cytoband | 1q32 | 1.49e-03 | 49 | 53 | 2 | 1q32 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q32 | 4.63e-03 | 290 | 53 | 3 | chr1q32 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 2.31e-09 | 9 | 39 | 4 | 1203 | |
| GeneFamily | Adiponectin receptors|Progestin and adipoQ receptor family | 4.53e-06 | 2 | 39 | 2 | 293 | |
| GeneFamily | Progestin and adipoQ receptor family | 2.46e-04 | 11 | 39 | 2 | 930 | |
| GeneFamily | ATP binding cassette subfamily B | 2.46e-04 | 11 | 39 | 2 | 806 | |
| GeneFamily | Lipases|Arylacetamide deacetylase family | 1.02e-03 | 22 | 39 | 2 | 464 | |
| GeneFamily | GCN5 related N-acetyltransferases | 1.21e-03 | 24 | 39 | 2 | 1134 | |
| GeneFamily | Transient receptor potential cation channels | 1.65e-03 | 28 | 39 | 2 | 249 | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 2.38e-06 | 180 | 53 | 5 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.26e-06 | 192 | 53 | 5 | 0bb06738e1c3ec0c044a7ee61f6cf1d4781fb53c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.43e-06 | 194 | 53 | 5 | be869e186386d03ebb670971dd24fa656b4b0edf | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.43e-06 | 194 | 53 | 5 | 4d6c9b016e3a0641954a8ea10c97d1cd76fadd9f | |
| ToppCell | severe-Lymphocytic-B_cells_2|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.08e-05 | 136 | 53 | 4 | 56a7b5c2e098b4a49124d1b905257a52eb38b519 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Crh_4930553C11Rik_|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.40e-05 | 141 | 53 | 4 | ad9a25569c142fb68ded34aeba0cd9be8124ce56 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.14e-05 | 151 | 53 | 4 | f4f7156b2c0cfc78fd1841e07c9915d97ced561f | |
| ToppCell | 367C-Epithelial_cells-Epithelial-B_(AT2)|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.76e-05 | 168 | 53 | 4 | e20e1936573fdde78426d7a4eb45c458d5c4dbb4 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-B_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.76e-05 | 168 | 53 | 4 | 16b517e3159ad6e6d25fd48f7d5f46e77b2b318d | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-erythrocytic-erythroid_lineage_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.99e-05 | 170 | 53 | 4 | 288014dedda8babc51fe08e48a55e68d83e1b1d2 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_2|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.10e-05 | 171 | 53 | 4 | 26b34dc069cc15b75a0c13cb8c5d81e074788160 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.83e-05 | 177 | 53 | 4 | dc846d0feb94d4c289553cc3ac9dac81d10409cb | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.83e-05 | 177 | 53 | 4 | f35b04c3557ebbdeba37dec54c8f45880eafb422 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.09e-05 | 179 | 53 | 4 | d3438fed0d85d5ed5afa8ff820c45143d77b6c0d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.50e-05 | 182 | 53 | 4 | 5f513bbb7125956eb528e3120de3fd776770a7c3 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.64e-05 | 183 | 53 | 4 | b5ede5a0048c585b73c00e88aeddbcaf669347b1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.64e-05 | 183 | 53 | 4 | d340ab5a77e8d819a1dfb4ca3e9a4b9bc988923c | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.78e-05 | 184 | 53 | 4 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 6.78e-05 | 184 | 53 | 4 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.92e-05 | 185 | 53 | 4 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.07e-05 | 186 | 53 | 4 | acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.07e-05 | 186 | 53 | 4 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.22e-05 | 187 | 53 | 4 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.22e-05 | 187 | 53 | 4 | f6217d0dd425eac76900b44a4e48f45475f3ac36 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.22e-05 | 187 | 53 | 4 | 2d17408b3b5f09d135084fd7ccce98e6b5ca632b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.22e-05 | 187 | 53 | 4 | e3095455d2f255854f339f6b05fa87852af0700f | |
| ToppCell | IPF-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 7.37e-05 | 188 | 53 | 4 | 5f5fad2773e421760e67dbace23fd1f847a2e1e0 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.37e-05 | 188 | 53 | 4 | 43a0508d2524a5b310e89e9422843dcaab999bc3 | |
| ToppCell | COVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type | 7.37e-05 | 188 | 53 | 4 | df1fd0819d301679f3c9ea404e942e39095912eb | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.52e-05 | 189 | 53 | 4 | 3a295c215b5c18e7c673f92b7af5be523421682c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.52e-05 | 189 | 53 | 4 | fc88c51ace7d883c01617f3f9b5fab70cc91cc09 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D231|Adult / Lineage, Cell type, age group and donor | 7.52e-05 | 189 | 53 | 4 | dab54a52358f66a8a9460cd6089a06c5fa7e7a5d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.52e-05 | 189 | 53 | 4 | 532aaf02b364c5c4f58a2021c7c21d86df3875c9 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.83e-05 | 191 | 53 | 4 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 7.83e-05 | 191 | 53 | 4 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 7.99e-05 | 192 | 53 | 4 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 7.99e-05 | 192 | 53 | 4 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 8.15e-05 | 193 | 53 | 4 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.15e-05 | 193 | 53 | 4 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.15e-05 | 193 | 53 | 4 | e7012f7b53971972299db34fa51ff51a4e4987fe | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.15e-05 | 193 | 53 | 4 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.32e-05 | 194 | 53 | 4 | 69bff17df4a760ccf081cf52ff04af02c14f448d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.32e-05 | 194 | 53 | 4 | 04bfc555743f7d8821439d05ae442d15e9886c59 | |
| ToppCell | COVID-19-Myeloid-Monocyte-derived_macrophages|COVID-19 / group, cell type (main and fine annotations) | 8.49e-05 | 195 | 53 | 4 | c172c5599379c29123340621a36bfb1fc90c2115 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.65e-05 | 196 | 53 | 4 | 7e5addaa844e66f8160e05858c341866a80aed23 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.65e-05 | 196 | 53 | 4 | 65e161fd672e37a5d10f28011bb422c4d7042d6a | |
| ToppCell | AT2_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 8.83e-05 | 197 | 53 | 4 | fd7bdfa6bf5966ebc11fdd13915769429540ddbf | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.83e-05 | 197 | 53 | 4 | bf10727fbe90b71d2ac60a11711e5f0701b3799d | |
| ToppCell | Severe-Plasmablast|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.83e-05 | 197 | 53 | 4 | 1089aa7991812378668d0f3d57f8000e6245a713 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.00e-05 | 198 | 53 | 4 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.00e-05 | 198 | 53 | 4 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.00e-05 | 198 | 53 | 4 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.00e-05 | 198 | 53 | 4 | f948391296c261c473d339069a6d0f20ccd6f38f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.00e-05 | 198 | 53 | 4 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD14|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.18e-05 | 199 | 53 | 4 | 1413156b7be5373fd02bbe39ec50ccfe165fa6d1 | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.18e-05 | 199 | 53 | 4 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.18e-05 | 199 | 53 | 4 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.18e-05 | 199 | 53 | 4 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | Biopsy_Other_PF-Epithelial-AT2|Biopsy_Other_PF / Sample group, Lineage and Cell type | 9.18e-05 | 199 | 53 | 4 | 9a65acfe9bf500db72142469cf17bf0973540001 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.18e-05 | 199 | 53 | 4 | a38a981cffa61c8444a980916de7414e689a1b63 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-B_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.18e-05 | 199 | 53 | 4 | df157604a7e2b6e7fa2d21660ca749a3552b945c | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Degenerative_Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.18e-05 | 199 | 53 | 4 | 5059a1d4df7d9989c922007a8dcba98b1f5687d5 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-B_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.18e-05 | 199 | 53 | 4 | 48626e54ce94b5ea3001fc5d447509a50c073aa4 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.18e-05 | 199 | 53 | 4 | a4ebb0598e9a0c9f6e39a0db6d0623654c2a7d88 | |
| ToppCell | Biopsy_IPF-Epithelial-AT2|Biopsy_IPF / Sample group, Lineage and Cell type | 9.18e-05 | 199 | 53 | 4 | c841d475703d3489161fb7904526bd7563d5fb0f | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar-AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.36e-05 | 200 | 53 | 4 | b535323e18d9fb0dde1e0026df142c831e48c29f | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 9.36e-05 | 200 | 53 | 4 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 9.36e-05 | 200 | 53 | 4 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 9.36e-05 | 200 | 53 | 4 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 9.36e-05 | 200 | 53 | 4 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 9.36e-05 | 200 | 53 | 4 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 9.36e-05 | 200 | 53 | 4 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 9.36e-05 | 200 | 53 | 4 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| Drug | N-(p-amylcinnamoyl)anthranilic acid | 2.38e-08 | 14 | 52 | 4 | CID000001974 | |
| Drug | APETx1, Anthopleura elegantissima | 2.24e-07 | 6 | 52 | 3 | ctd:C475726 | |
| Drug | 2,3,5,6-tetrafluoro-4-methylbenzyl (Z)-(1RS)-cis-3-(2-chloro-3,3,3-trifluoroprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate | 6.24e-07 | 8 | 52 | 3 | ctd:C489827 | |
| Drug | Zonisamide | 7.47e-06 | 17 | 52 | 3 | DB00909 | |
| Drug | palmitoylacetylglycerol | 1.53e-05 | 3 | 52 | 2 | CID000146026 | |
| Drug | metformin | 1.55e-05 | 235 | 52 | 6 | CID000004091 | |
| Drug | APETx2 protein, Anthopleura elegantissima | 3.06e-05 | 4 | 52 | 2 | ctd:C501880 | |
| Drug | nafazatrom | 3.94e-05 | 29 | 52 | 3 | CID000042923 | |
| Drug | Sodium | 4.08e-05 | 84 | 52 | 4 | ctd:D012964 | |
| Drug | guanosine 3',5'-cyclic monophosphoric acid | 4.57e-05 | 577 | 52 | 8 | CID000000295 | |
| Drug | AC1L9K72 | 5.05e-05 | 290 | 52 | 6 | CID000446872 | |
| Drug | 1-stearoyl-2-arachidonoylglycerol | 5.09e-05 | 5 | 52 | 2 | ctd:C075809 | |
| Drug | lauroylcarnitine | 5.09e-05 | 5 | 52 | 2 | CID000168381 | |
| Drug | 1-acetyl-sn-glycero-3-phosphocholine | 6.67e-05 | 305 | 52 | 6 | CID005311264 | |
| Drug | lecithin | 6.67e-05 | 305 | 52 | 6 | CID010425705 | |
| Drug | 1-methylanthracene | 7.63e-05 | 6 | 52 | 2 | CID000011884 | |
| Drug | fenpropathrin | 7.63e-05 | 6 | 52 | 2 | ctd:C044267 | |
| Drug | aminoparathion | 7.63e-05 | 6 | 52 | 2 | CID000000220 | |
| Drug | Indoprofen [31842-01-0]; Up 200; 14.2uM; PC3; HT_HG-U133A | 8.61e-05 | 197 | 52 | 5 | 4249_UP | |
| Drug | nordihydroguaiaretic acid; Up 200; 1uM; PC3; HT_HG-U133A | 9.25e-05 | 200 | 52 | 5 | 4447_UP | |
| Drug | bosentan | 1.01e-04 | 106 | 52 | 4 | CID000104865 | |
| Drug | Tetrodotoxin | 1.05e-04 | 40 | 52 | 3 | ctd:D013779 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.79e-09 | 10 | 52 | 4 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.79e-09 | 10 | 52 | 4 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 4.20e-09 | 12 | 52 | 4 | DOID:0060170 (implicated_via_orthology) | |
| Disease | hyperinsulinism (biomarker_via_orthology) | 2.31e-06 | 15 | 52 | 3 | DOID:2018 (biomarker_via_orthology) | |
| Disease | anxiety disorder (implicated_via_orthology) | 7.76e-06 | 22 | 52 | 3 | DOID:2030 (implicated_via_orthology) | |
| Disease | Benign familial infantile epilepsy | 9.13e-06 | 3 | 52 | 2 | cv:C5575231 | |
| Disease | Familial benign neonatal epilepsy | 4.55e-05 | 6 | 52 | 2 | C0220669 | |
| Disease | Seizure, Febrile, Simple | 6.36e-05 | 7 | 52 | 2 | C0149886 | |
| Disease | Seizure, Febrile, Complex | 6.36e-05 | 7 | 52 | 2 | C0751057 | |
| Disease | MASA syndrome (implicated_via_orthology) | 6.36e-05 | 7 | 52 | 2 | DOID:0060246 (implicated_via_orthology) | |
| Disease | Febrile Convulsions | 1.09e-04 | 9 | 52 | 2 | C0009952 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 1.09e-04 | 9 | 52 | 2 | C3502809 | |
| Disease | Diabetic Retinopathy | 1.66e-04 | 11 | 52 | 2 | C0011884 | |
| Disease | epilepsy (implicated_via_orthology) | 1.98e-04 | 163 | 52 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | X-Linked Csnb | 1.99e-04 | 12 | 52 | 2 | C3711543 | |
| Disease | Night blindness, congenital stationary, type 1 | 1.99e-04 | 12 | 52 | 2 | C3501847 | |
| Disease | Night Blindness, Congenital Stationary, Type 1A | 1.99e-04 | 12 | 52 | 2 | C3495587 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B (disorder) | 1.99e-04 | 12 | 52 | 2 | C1864877 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A | 1.99e-04 | 12 | 52 | 2 | C1848172 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B | 1.99e-04 | 12 | 52 | 2 | C1850362 | |
| Disease | Infantile Severe Myoclonic Epilepsy | 2.35e-04 | 13 | 52 | 2 | C0751122 | |
| Disease | Cone-rod synaptic disorder, congenital nonprogressive | 2.35e-04 | 13 | 52 | 2 | C4041558 | |
| Disease | Hamman-Rich syndrome | 2.73e-04 | 14 | 52 | 2 | C0085786 | |
| Disease | MMR-related febrile seizures | 3.15e-04 | 15 | 52 | 2 | EFO_0006519 | |
| Disease | Early infantile epileptic encephalopathy with suppression bursts | 3.60e-04 | 16 | 52 | 2 | C0393706 | |
| Disease | Night blindness, congenital stationary | 4.07e-04 | 17 | 52 | 2 | C0339535 | |
| Disease | Epilepsy, Cryptogenic | 4.14e-04 | 82 | 52 | 3 | C0086237 | |
| Disease | Awakening Epilepsy | 4.14e-04 | 82 | 52 | 3 | C0751111 | |
| Disease | Aura | 4.14e-04 | 82 | 52 | 3 | C0236018 | |
| Disease | Febrile seizure (within the age range of 3 months to 6 years) | 4.58e-04 | 18 | 52 | 2 | HP_0002373 | |
| Disease | Hypercholesterolemia, Familial | 4.58e-04 | 18 | 52 | 2 | C0020445 | |
| Disease | Neurodevelopmental Disorders | 5.99e-04 | 93 | 52 | 3 | C1535926 | |
| Disease | Idiopathic Pulmonary Fibrosis | 6.26e-04 | 21 | 52 | 2 | C1800706 | |
| Disease | Retinitis Pigmentosa | 8.29e-04 | 104 | 52 | 3 | C0035334 | |
| Disease | Epilepsy | 9.50e-04 | 109 | 52 | 3 | C0014544 | |
| Disease | Myocardial Failure | 9.75e-04 | 110 | 52 | 3 | C1959583 | |
| Disease | Congestive heart failure | 9.75e-04 | 110 | 52 | 3 | C0018802 | |
| Disease | Heart failure | 9.75e-04 | 110 | 52 | 3 | C0018801 | |
| Disease | Left-Sided Heart Failure | 9.75e-04 | 110 | 52 | 3 | C0023212 | |
| Disease | Heart Failure, Right-Sided | 9.75e-04 | 110 | 52 | 3 | C0235527 | |
| Disease | Heart Decompensation | 9.75e-04 | 110 | 52 | 3 | C1961112 | |
| Disease | macular degeneration (is_implicated_in) | 1.04e-03 | 27 | 52 | 2 | DOID:4448 (is_implicated_in) | |
| Disease | Subfertility, Female | 1.12e-03 | 28 | 52 | 2 | C0341869 | |
| Disease | Sterility, Postpartum | 1.12e-03 | 28 | 52 | 2 | C0038279 | |
| Disease | Female sterility | 1.12e-03 | 28 | 52 | 2 | C0917730 | |
| Disease | Female infertility | 1.12e-03 | 28 | 52 | 2 | C0021361 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 1.13e-03 | 447 | 52 | 5 | EFO_0000694, MONDO_0100096 | |
| Disease | Intellectual Disability | 1.13e-03 | 447 | 52 | 5 | C3714756 | |
| Disease | arteriosclerosis (is_implicated_in) | 1.37e-03 | 31 | 52 | 2 | DOID:2349 (is_implicated_in) | |
| Disease | Bipolar Disorder | 1.50e-03 | 477 | 52 | 5 | C0005586 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VYTAMEYRWPFGNYL | 86 | P30556 | |
| PFSLANELMAYWYFG | 106 | P18825 | |
| YIPYFFVAPRYNWMT | 386 | Q99758 | |
| YIIQLYMPLNWFGTY | 536 | Q9NP58 | |
| YMPLNWFGTYYRMIQ | 541 | Q9NP58 | |
| AYIIIYGMPTYWLAN | 506 | Q9H221 | |
| FNSFEPYYMWDYVAR | 426 | Q5JWR5 | |
| YDYIWDFIFYPNGVM | 461 | P19801 | |
| YWYFYGTRMYKEDPV | 156 | Q9BXF3 | |
| WYGAYLVNAYPLDMS | 201 | P23786 | |
| LIMGSFVPWLYYSFY | 226 | Q86V24 | |
| YPQYYLAEPWQFSML | 26 | P08100 | |
| IMGSFVPWLYYSFYC | 216 | Q96A54 | |
| AFLSGYMWYNIIQYF | 351 | Q92604 | |
| YQMKYYFYHGLSWPQ | 26 | P41227 | |
| YTFTGYYMHWVRQAP | 46 | P23083 | |
| KPAGVYYATAYWMPA | 36 | Q6P4A8 | |
| FPWMLAYVFYYPVLH | 201 | Q5VTY9 | |
| YMQFAAAAYGWPLYI | 281 | Q8NCG7 | |
| TWAVYERPNFAGYMY | 46 | P22914 | |
| MYSYFMFTRGGPYWQ | 236 | Q9Y375 | |
| RYLMYPGWYEGKLNA | 951 | Q5TEA3 | |
| YVAYTIWGSVMYPYQ | 81 | Q96PG1 | |
| IYHFPAYQWMDGYET | 96 | O75342 | |
| EVCYYMLFALAAYGW | 291 | Q9Y4D2 | |
| LMVFVNYGGGKYWYF | 281 | Q68CP4 | |
| LTGVYYAMYNGQWDL | 241 | Q8IXS8 | |
| YYLPGMASIYAAWLG | 281 | Q8NH67 | |
| GYFDGHVWPMYLKYR | 141 | Q9NWW6 | |
| MYLGLAWSYVVYYSP | 196 | P27169 | |
| DVPFSAMYWYNYEIL | 206 | Q8TBP6 | |
| PLMDNWYSLSYLYFS | 511 | Q8N695 | |
| FIEYMDQGPWYLAFY | 496 | Q9UKZ4 | |
| IVGFAMYYFTYDPWI | 71 | P21673 | |
| MYYFTYDPWIGKLLY | 76 | P21673 | |
| IIAMDPYYYFQEGWN | 811 | Q9NY46 | |
| YRAFLAAYPFVNMAW | 156 | O00623 | |
| AMDPYYYFQEGWNIF | 821 | P35498 | |
| EMLLKWVAYGYQTYF | 1266 | P35498 | |
| LNRKEAAAYMYYVWG | 401 | Q9NP78 | |
| PCGEYAMFIAWLYKY | 386 | P42695 | |
| YYNWLFCITLPVMYN | 161 | P29973 | |
| GVIWPFLNYQRMYYV | 1051 | P98196 | |
| EYDGKINAWDLYYYM | 351 | Q9BYT8 | |
| YFYMVSAWGGYVFII | 256 | Q8TCJ2 | |
| YMPYWMIYGEVFADQ | 1071 | Q9HCF6 | |
| IAMDPYYYFQEGWNI | 811 | Q99250 | |
| DYMQYPVFPWVLADY | 2566 | Q6ZS81 | |
| AMDPYYYFQEGWNIF | 806 | Q9UQD0 | |
| FAAWMAYYINHPLYT | 171 | Q9NZ01 | |
| YWVRYQGPYVSMAFI | 671 | Q8TE23 | |
| FLGYMQYSIVDYCWL | 266 | Q8IY26 | |
| NIFYMPYWMIYGEVF | 1001 | Q7Z4N2 | |
| GFMLLFYQYLYPWQS | 391 | Q5GH77 | |
| MPSFWSLQAYYTRYF | 106 | Q9Y6M0 | |
| YAKYWIYVCAGMFIV | 576 | Q92508 | |
| RIPEWLFVASYYMAY | 271 | P48039 |